Search Results - "Jouhaud, A"
-
1
Postoperative irinotecan in resected stage II–III rectal cancer: final analysis of the French R98 Intergroup trial
Published in Annals of oncology (01-06-2015)“…The R98 trial explores the addition of irinotecan to a 5-fluorouracil (5-FU) plus leucovorin (5-FU/LV) adjuvant regimen in optimally resected stages II–III…”
Get full text
Journal Article -
2
The Henri Mondor Procedure of Morbidity and Mortality Reviews (MMR) Meetings: Prospective Registration of Clinical, Dosimetric, and Individual Biological Radiosensitivity Data of Patients With Severe Radiation Toxicity
Published in International journal of radiation oncology, biology, physics (01-11-2015)Get full text
Journal Article -
3
Impact of on-site initiation visits on patient recruitment and data quality in a randomized trial of adjuvant chemotherapy for breast cancer
Published in Clinical trials (London, England) (01-01-2006)“…Purpose To provide empirical evidence on the impact of on-site initiation visits on the following outcomes: patient recruitment, quantity and quality of data…”
Get full text
Journal Article -
4
Impact Of Cytoterm On Vasomotor Symptoms (VMS) And Quality Of Life (Qol) Impairments In Patients Receiving Hormone Therapy (HT) And Radiotherapy (RT) For Prostate Cancer (Pca). Results Of The ESCULAPE Phase II Study
Published in International journal of radiation oncology, biology, physics (01-11-2020)Get full text
Journal Article -
5
-
6
-
7
-
8
Radiothérapie hémostatique dans le cancer de la vessie chez les patients inopérables : quel impact du fractionnement ?
Published in Cancer radiothérapie (01-10-2018)“…L’objectif de notre étude était d’évaluer l’efficacité hémostatique à court et à long termes de deux schémas de fractionnement de radiothérapie externe pour le…”
Get full text
Journal Article -
9
Postoperative irinotecan in resected stage II-III rectal cancer: final analysis of the French R98 Intergroup trial
Published in Annals of oncology (01-06-2015)“…The R98 trial explores the addition of irinotecan to a 5-fluorouracil (5-FU) plus leucovorin (5-FU/LV) adjuvant regimen in optimally resected stages II-III…”
Get full text
Journal Article